Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this presentation? Why not share!

Employer Branding Stefan Gijssels, Janssen Pharmaceutica

on

  • 747 views

 

Statistics

Views

Total Views
747
Views on SlideShare
747
Embed Views
0

Actions

Likes
1
Downloads
18
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Sales Volume of Janssen Pharmaceutica N.V. The sales volume, or turnover, has grown steadily over the years both in Belgium and abroad. In particular, the increase in exports in the past few years is striking. Belgium: 1999: 90 - 2000: 85 - 2001: 98 - 2002: 97 - 2003: 99 - 2004: 87 Abroad: 1999: 1,101 - 2000: 1,131 - 2001: 1,470 - 2002: 1,577 - 2003: 1,777 - 2004: 1,847 Total: 1999: 1,191 - 2000: 1,216 - 2001: 1,568 - 2002: 1,674 - 2003: 1,876 - 2004: 1,934

Employer Branding Stefan Gijssels, Janssen Pharmaceutica Employer Branding Stefan Gijssels, Janssen Pharmaceutica Presentation Transcript

  • Employer Branding Stefan Gijssels, Janssen Pharmaceutica 10/29/10
  • 10/29/10 The most attractive employer?
  • 10/29/10
  • Sales Volume of Janssen Pharmaceutica N.V. million euros
  • R&D Investments by Janssen Belgium 10/29/10 In millions of euro
  • Employment at Janssen in Belgium 10/29/10
  • Randstad survey : Most Attractive Employer Percentage of people that spontaneously mention they want to work for company X 2 1 3 3 3 1 1 4 7 Period of intense and pro-active media relations & stakeholder engagement Period of company reorganisation & reactive external outreach 1
  • The fundamental questions?
    • Who Are We?
    • How does the environment change?
    • Where do we go?
    • Who do we want to be?
    • How will we differentiate ourselves?
    • What are our values?
    • What do we want to achieve?
    • By when?
    • How will we measure success?
    10/29/10
  • Employer branding???? Which brand??? 10/29/10
  • 10/29/10
  • 10/29/10
  •  
  • We will tackle the five areas of high global unmet medical need 10/29/10 Oncology Breast, lung, prostate, B-cell malignancies, colorectal cancer Immunology Rheumatoid arthritis, psoriasis and pulmonary diseases Cardiovascular & Metabolism Heart disease, diabetes and obesity Neuroscience Schizophrenia, bipolar, Alzheimer’s and pain Infectious Diseases HIV/AIDS, Hepatitis C, tuberculosis and influenza
  • Vision & Mission
    • Janssen EMEA will lead fundamental change in the way diseases are managed
    • In our absolute commitment to patients , we will build innovative, integrated healthcare solutions that will restore and extend the quality of life, while at the same time creating economic value for society and our company.
    • We will achieve this by working side-by-side with healthcare stakeholders
    • We will focus our energy on five major therapeutic areas of unmet need:
      • Neuroscience (schizophrenia, dementia, pain …),
      • Infectious Diseases (HIV/AIDS, Hepatitis C, tuberculosis, …),
      • Oncology (multiple myeloma, prostate cancer, …),
      • Immunology (psoriasis, rheumatoid arthritis, …),
      • Metabolism (diabetes, obesity, …).
    • We will continue to invest in our people to realize their personal growth and to build our leaders of the future
    10/29/10
  • 10/29/10 We Will Find Best Innovation Wherever It Exists External Innovation Academia Biotech Pharma Consortia The world is our laboratory
  • Our aspiration 10/29/10 Good for society Not good for society Unprofitable Highly profitable
  • Pharmaceutical companies : global ranking 10/29/10 Rank Company Total Revenues (US$ billions) R&D Expenses (reported currency in millions) 1 Pfizer 50,01 $7,845 2 Roche 47,35 CHF 9,874 3 GlaxoSmithKline 45,83 £4,106 4 Novartis 44,27 $7,469 5 Sanofi-Aventis 41,99 € 4,583 6 AstraZeneca 32,81 $4,409 7 Abbott Laboratories 30,76 $2,744 8 Merck & Co. 27,43 $5,800 9 Janssen 22,50 $4,591 10 Bayer HealthCare 22,30 € 1,845 11 Eli Lilly 21,84 N/A 12 Bristol-Myers Squibb 18,81 $3,647
  • The four P’s : excel in all areas
    • Product
    • People
    • Planet
    • Profit
    10/29/10
    • High therapeutic added value
      • Cancer, Aids, alzheimer’s, diabetes, tuberculosis
    • Best talent, diversity, safety, training, career mentoring, ....
    • Sustainability programs, WWF Climate Champion, 100% green energy in Belgium, “Design For Environment”, ....
    • Challenging times, but excellent long-term perspectives
    GOALS METRICS PROGRAMS
  • Communications is key
    • Job recruitment days
    • Media relations
    • Company visits
    • Web-based communications
    • Sustainability reports
    • Lots and lots of direct engagement and contacts
    • “ 14 Imperatives of improved communications”
    10/29/10
  • EMEA website Company story Advertisements Posters EMEA Newsletter EMEA Intranet Videos New design and new materials Screensaver 10/29/10 They want to know who we are …
  • 10/29/10
  • Conclusion
    • What is key in having a good employer branding :
      • Success salary, job security, long term perspective, innovation, training, ...
      • International career opportunities, self-development, ...
      • Proximity familiar, low threshold, ...
      • Values diversity, environment, workplace environment, safety, work-life balance, training, ...
    10/29/10
  • 10/29/10 The most attractive employer!
  • Thank You